HAUPTMENÜ

DOC-CHECK LOGIN

Anti-Swine Flu Vaccination Linked to Increased Risk of Narcolepsy in Young Adults

Stockholm, Sweden (January 21, 2014) – Pandemrix is an influenza vaccination, created in 2009 to combat H1N1, known as Swine Flu. Now, a team of Swedish clinicians testing the vaccine for links to immune-related or neurological diseases have linked Pandemrix to an increased risk of narcolepsy in young adults.

Using a population-based prospective cohort study, the team analyzed data from regional vaccination registries and national health registries, covering seven healthcare regions and 61% of the Swedish population.

While the team did not identify any link to a large number of immune-related or neurological diseases, they did confirm an increased risk in diagnosis of narcolepsy in individuals younger than 20 years of age, and observed a trend towards an increased risk amongst young adults between 21 and 30.

“The follow-up of Pandemrix vaccinations in a large registry based study in Sweden confirms an increased risk of narcolepsy in children and adolescents, while also providing reassuring results for a large number of other neurological and immune related diseases,” said Dr. I. Persson from the Karolinska Institutet

Link

• http://onlinelibrary.wiley.com/journal/10.1111/(ISSN)1365-2796;jsessionid=BDAA8CF461E450898F471BF5597E0B43.f02t02

Journal of Internal Medicine, 21.01.2014 (tB).